12th Drug Discovery Innovation Programme (DDIP) is a unique platform to meet senior level executives, key decision makers and experts from Pharmaceutical, Biotech and Lead Scientists making the congress a perfect platform to share experience and foster collaborations to put forward many thought provoking strategies.

WHAT TO EXPECT 
  • 12+ Networking Hours
  • 25+ Countries Representation
  • 20+ Keynote Speakers 
  • 250+ Pre-Qualified meeting
  • 75:25 Buyers:Sellers
  • 80+ Attendees

Top-level Industry leaders from around 25+ countries come to join DDIP and leave with an exceptional experience that they return to the conferences year after year. Delegates attending the event are asked to complete a questionnaire, which confirms their R&D budget. They also provide details on:

  • Relevant Drug Discovery phases
  • Drug Discovery budget of over 1 million Euros​
  • Scope of responsibility​
  • Purchase plan for Products and services
  • Geographies of interest​
  • Key priorities for the next 6-18 months 

DDIP is Co-Located with 16th Clinical Trials Innovation Programme (CTIP) and 4th Medical Devices Innovation Programme in Boston.